A Triple‐Kill Strategy for Tumor Eradication Reinforced by Metal‐Phenolic Network Nanopumps
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Triple‐Kill Strategy for Tumor Eradication Reinforced by Metal‐Phenolic Network Nanopumps
Authors
Keywords
-
Journal
ADVANCED FUNCTIONAL MATERIALS
Volume -, Issue -, Pages 2113168
Publisher
Wiley
Online
2022-02-11
DOI
10.1002/adfm.202113168
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bioorthogonal Coordination Polymer Nanoparticles with Aggregation‐Induced Emission for Deep Tumor‐Penetrating Radio‐ and Radiodynamic Therapy
- (2021) Jingjing Liu et al. ADVANCED MATERIALS
- Quantum monitoring of cellular metabolic activities in single mitochondria
- (2021) L. Nie et al. Science Advances
- In situ cancer vaccination using lipidoid nanoparticles
- (2021) Jinjin Chen et al. Science Advances
- Recent Advances in Metal‐Phenolic Networks for Cancer Theranostics
- (2021) Zhan Zhang et al. Small
- Self-Delivery Nanomedicine for O2-Economized Photodynamic Tumor Therapy
- (2020) Lin-Ping Zhao et al. NANO LETTERS
- Durvalumab and tremelimumab combination therapy versus durvalumab or tremelimumab monotherapy for patients with solid tumors
- (2020) Bi-Cheng Wang et al. MEDICINE
- Polyphenol‐based Nanomedicine Evokes Immune Activation for Combination Cancer Treatment
- (2020) Zhan Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination
- (2020) Kaiyuan Ni et al. Science Advances
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy
- (2020) Lisi Xie et al. BIOMATERIALS
- Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
- (2019) Qian Chen et al. ADVANCED MATERIALS
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial
- (2019) Sylvie Bonvalot et al. LANCET ONCOLOGY
- Rational combinations of immunotherapy with radiotherapy in ovarian cancer
- (2019) Fernanda G Herrera et al. LANCET ONCOLOGY
- Aggregation-Induced Emission Gold Clustoluminogens for Enhanced Low-Dose X-ray-Induced Photodynamic Therapy
- (2019) Wenjing Sun et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Metal-organic frameworks for multimodal bioimaging and synergistic cancer chemotherapy
- (2019) Zhan Zhang et al. COORDINATION CHEMISTRY REVIEWS
- Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self-Assembled Metal-Phenolic Network Nanoparticles
- (2018) Yunlu Dai et al. ADVANCED MATERIALS
- Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer
- (2018) Yunhui Hu et al. CANCER LETTERS
- Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
- (2018) Young Kwang Chae et al. Journal for ImmunoTherapy of Cancer
- Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy
- (2018) Kuangda Lu et al. Nature Biomedical Engineering
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- Tumour cell-intrinsic CTLA4 regulates PD-L1 expression in non-small cell lung cancer
- (2018) Huijun Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade
- (2018) Silvia C. Formenti et al. NATURE MEDICINE
- Radiotherapy and immunotherapy: a beneficial liaison?
- (2017) Ralph R. Weichselbaum et al. Nature Reviews Clinical Oncology
- Recent Developments in Radiotherapy
- (2017) Deborah E. Citrin NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?
- (2016) Michael B. Bernstein et al. Nature Reviews Clinical Oncology
- Cell-cycle-controlled radiation therapy was effective for treating a murine malignant melanoma cell line in vitro and in vivo
- (2016) Keisuke Otani et al. Scientific Reports
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy
- (2014) Susan M. Hiniker et al. Translational Oncology
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started